THE CONTRIBUTION OF TERTIARY CENTERS TO THE QUALITY OF THE DIAGNOSIS AND TREATMENT OF EPILEPSY

Citation
G. Avanzini et al., THE CONTRIBUTION OF TERTIARY CENTERS TO THE QUALITY OF THE DIAGNOSIS AND TREATMENT OF EPILEPSY, Epilepsia, 38(12), 1997, pp. 1338-1343
Citations number
21
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
00139580
Volume
38
Issue
12
Year of publication
1997
Pages
1338 - 1343
Database
ISI
SICI code
0013-9580(1997)38:12<1338:TCOTCT>2.0.ZU;2-O
Abstract
Purpose: A survey was made of a network of 14 epilepsy centers in Ital y to assess whether integrated diagnosis and treatment monitoring led to a more precise syndromic classification of the patients and a bette r response to treatment.Methods: Data on the diagnosis and treatment o f epilepsy and the degree of seizure control were recorded in a regist er on 2 separate occasions, on June 30, 1990 (t0), before starting the integrated activities, and on June 30, 1992 (t1), on completion of a 2-year follow-up. Each patient's history was required to fit a specifi c category of the International Classification of the Epilepsies (ICE) (1). Response to treatment was classified as complete remission, occa sional seizures, recurrent nonrefractory seizures, and drug-resistant epilepsy. A total of 3,469 patients of the ages of 4-80 years were enr olled. Results: At t0, 44% of cases had localization-related epilepsy, 31% generalized epilepsy, 9% undetermined epilepsy, 6% special syndro mes, and 10% epileptic syndromes with atypical features. At t1, the pe rcentages in each category were 51, 27, 7, 6, and 9%. The cases classi fied as ''other'' within each syndromic category at t0 were 11-23% and remained unchanged at t1. Patients with symptomatic localization-rela ted epilepsies were largely recoded as symptomatic of cryptogenic epil epsies. About one-third of patients with symptomatic generalized epile psy were recoded as localization-related epilepsies. Nine percent of p atients were classified as ''uncertain'' epilepsies at t0, and the sam e proportion at t1. However, many ''uncertain'' diagnoses became ''def inite'' and vice versa. Conclusions: There was a slight increase in th e proportion of patients achieving complete remission (from 13 to 28%) and untreated patients (from 10 to 17%). Nine percent of patients unr esponsive to treatment at t0 had achieved remission at t1. Drug resist ance was confirmed in 78% of cases and was mostly independent of the t herapeutic decision. Ten percent of cases achieved remission with unch anged or simplified treatment schedules.